Cargando…
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort
Melanoma is a highly aggressive cancer, attracting increasing attention worldwide. The 5-year survival rate of patients with metastatic melanoma is low. Therefore, it is critical to identify potential effective biomarkers for diagnosis of melanoma metastasis. In the present study, the melanoma cohor...
Autores principales: | Sheng, Yang, Yanping, Cheng, Tong, Liu, Ning, Liu, Yufeng, Liu, Geyu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136491/ https://www.ncbi.nlm.nih.gov/pubmed/32296685 http://dx.doi.org/10.3389/fbioe.2020.00206 |
Ejemplares similares
-
Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer
por: Yaman, Serkan, et al.
Publicado: (2020) -
Recent Progress in Nanomedicine for Melanoma Theranostics With Emphasis on Combination Therapy
por: Guan, Mengqi, et al.
Publicado: (2021) -
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
por: Lv, Lei, et al.
Publicado: (2021) -
Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma
por: Hou, Chongchao, et al.
Publicado: (2022) -
Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
por: Xiong, Wei, et al.
Publicado: (2022)